---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-112904"
form_type: "8-K"
ticker: "KALV"
cik: "0001348911"
company_name: "KalVista Pharmaceuticals, Inc."
filed_at: "2024-10-04T23:59:59+00:00"
generated_at: "2026-05-30T19:54:21.681187+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# KalVista shareholders elect directors, ratify auditor, approve say-on-pay at 2024 annual meeting

## Summary
- William Fairey and Nancy Stuart elected as Class III directors with 30.2M and 19.3M votes 'For', respectively; Stuart faced 11.7M votes 'Against'.
- Deloitte & Touche ratified as independent auditor for FY ending April 30, 2025 with 39.3M votes 'For'.
- Advisory say-on-pay proposal approved with 26.6M 'For', 4.5M 'Against'.
- Broker non-votes of 8.3M shares recorded for director election and say-on-pay proposals.

## SEC filing metadata
- accession: 0000950170-24-112904
- form_type: 8-K
- ticker: KALV
- cik: 0001348911
- company_name: KalVista Pharmaceuticals, Inc.
- filed_at: 2024-10-04T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1348911/000095017024112904/0000950170-24-112904-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1348911/000095017024112904/kalv-20241003.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-112904
- JSON: https://secwatch.observer/filing/0000950170-24-112904.json
- Plain text: https://secwatch.observer/filing/0000950170-24-112904.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.